Stock Market - Why would the Fed cut interest rates a 3rd time in a row even as stocks near records? Investors may soon find out |
- Why would the Fed cut interest rates a 3rd time in a row even as stocks near records? Investors may soon find out
- Why the U.S. economy’s bumpy ride is about to get bumpier
- Machine Generated Signals. "OCT19 WK5" Weekly Stocks| HUD �� & ABBV �� (Exp. Nov 1st)
- Will Agile Therapeutics' Twirla Get FDA Approval? AGRX
- 3 SGX Stocks With Strong Cash Flow
| Posted: 27 Oct 2019 10:45 AM PDT Is three the magic number for Wall Street? We'll soon find out. Only a few think that Jerome Powell & Co. will not cut interest rates next week for a third time in as many gatherings of the rate-setting Federal Open Market Committee. Market-based probabilities imply a 93.5% chance of a quarter-of-a-percentage-point rate reduction to a 1.50%-1.75% range from the current 1.75%-2%, following the two-day Oct. 29-30 meeting, according to CME Group based on federal-funds futures. [link] [comments]  |
| Why the U.S. economy’s bumpy ride is about to get bumpier Posted: 27 Oct 2019 10:39 AM PDT A barrage of reports on the economy this coming week are expected to show U.S. growth slowed at the end of the summer. The smoldering trade war with China has sapped business investment, undercut American manufacturers and farmers and caused a decline in hiring. The first big clue will come Wednesday. Gross domestic product in the third quarter running from July to September is forecast to fall to about 1.4% from a 2% pace of growth in the spring. https://www.marketwatch.com/story/why-the-us-economys-bumpy-ride-is-about-to-get-bumpier-2019-10-26 [link] [comments]  |
| Machine Generated Signals. "OCT19 WK5" Weekly Stocks| HUD �� & ABBV �� (Exp. Nov 1st) Posted: 27 Oct 2019 08:24 PM PDT Machine Generated Signals. "OCT19 WK5" Weekly Stocks| HUD 📈 & ABBV 📈 (Exp. Nov 1st) [link] [comments]  |
| Will Agile Therapeutics' Twirla Get FDA Approval? AGRX Posted: 27 Oct 2019 10:55 AM PDT Will the third time be a charm for Agile Therapeutics Twirla, kind of like the linked article suggests? AdCom is on the 30th follow by the FDA decision next month. $AGRX has been trading between 1.00 and 1.35 for a month or two and didn't have the run-up prior to AdCom that many would have expected. Maybe it happens this week after the meeting notes are released. I just can't imagine the company fails again when the only issue the last time they were denied was adhesion, which has been resolved in the wear study. I'm open to ideas and thoughts though!! https://www.medtechy.com/articles/2019/will-the-third-time-be-a-charm-for-agile-therapeutics [link] [comments]  |
| 3 SGX Stocks With Strong Cash Flow Posted: 27 Oct 2019 06:49 AM PDT |
| You are subscribed to email updates from r/StockMarket - Reddit's front page of the stock market, financial news. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment